A vial of Novavax's COVID-19 vaccine Nuvaxovid at GGD Utrecht in Nieuwegein, The Netherlands, 15 March 2022. The vaccine is intended for adults who have not yet been vaccinated against the coronavirus and who object to the so-called mRNA vaccines that are used as standard.  ANSA/JEROEN JUMELET